Cost-effectiveness analysis of olaparib maintenance therapy for BRCA mutation ovarian cancer in the public sector in Malaysia. Yong CM, Yehgambaram PAP, Lee SWH. PLoS One 2024;19:e0298130.

Read + Share

Amedeo Smart

Independent Medical Education

Read + Share

Yong CM, Yehgambaram PAP, Lee SWH. Cost-effectiveness analysis of olaparib maintenance therapy for BRCA mutation ovarian cancer in the public sector in Malaysia. PLoS One 2024;19:e0298130.
PMID: 38300930